Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Operating activities:
Net income (loss)	$ (263,119)	$ 412,869
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	25,016	17,828
Amortization of debt discount	1,875	3,325
Amortization of debt issuance costs	0	34,804
Stock compensation Expense	50,777	70,365
Change in fair value of derivative instruments	178,844	16,721
Gain from the sale of Product Line	0	(499,525)
Change in assets and liabilities
Accounts receivable	63,098	(163,918)
Notes receivable	0	2,673
Inventories	(68,624)	(111,026)
Prepaid expenses	36,810	66,279
Deposits and other assets	1,041	5,462
Accounts payable	237,372	101,162
Accrued expenses	(133,533)	(56,864)
Income taxes	0	254,734
Net cash provided by operating activities	129,557	154,889
Cash flows from investing activities:
Purchase of property and equipment	(64,462)	(7,520)
Proceeds from the sale of Product Line	0	500,000
Marketable securities	54,485	0
Redemption of Investments	965,886	0
Net cash provided by investing activities	846,939	492,480
Cash flows from financing activities:
Proceeds of notes payable	23,888	0
Payment of notes payable	0	(54,290)
Payment of vendor notes	0	(1,000)
Proceeds from line of credit	0	1,980,481
Repayment of line of credit	0	(1,828,858)
Deferred offering costs	0	(193,201)
Distributions to shareholder	0	(41,436)
Net cash provided by (used in) financing activities	23,888	(138,304)
Net increase in cash	1,000,384	509,065
Cash and cash equivalents, beginning of period	1,655,453	364,608
Cash and cash equivalents, end of period	2,655,837	873,673
Supplemental Disclosure of Cash Flow Information
Cash paid for interest	11,929	63,394
Non-cash transactions
Conversion of notes payable to common stock	$ 0	$ 250,000